Universe Pharmaceuticals INC (NYSE:UPC – Get Free Report) was down 0.2% on Monday . The company traded as low as $0.50 and last traded at $0.50. Approximately 221,700 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 644,712 shares. The stock had previously closed at $0.50.
Universe Pharmaceuticals Price Performance
The firm has a 50-day simple moving average of $0.95 and a two-hundred day simple moving average of $17.61.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Universe Pharmaceuticals stock. MML Investors Services LLC bought a new stake in Universe Pharmaceuticals INC (NYSE:UPC – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned approximately 6.46% of Universe Pharmaceuticals as of its most recent SEC filing. 0.18% of the stock is currently owned by hedge funds and other institutional investors.
About Universe Pharmaceuticals
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Read More
- Five stocks we like better than Universe Pharmaceuticals
- What Do S&P 500 Stocks Tell Investors About the Market?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How to Invest in Small Cap Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Start Investing in Real Estate
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.